Real-World study shows dupilumab may ease severe asthma symptoms
NCT ID NCT06018441
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 22 times
Summary
This study followed 112 adults with severe asthma who started taking dupilumab (Dupixent®) to see how their quality of life changed over a year. Researchers measured breathing, activity, and emotional well-being using a standard questionnaire. The goal was to understand the drug's real-world benefits beyond controlled clinical trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Investigational Site
France, France
Conditions
Explore the condition pages connected to this study.